These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17459556)

  • 21. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of new lipophilic chelators on the activities of cytosolic reductases and P450 cytochromes involved in the metabolism of anthracycline antibiotics: studies in vitro.
    Schröterová L; Kaiserová H; Baliharová V; Velík J; Gersl V; Kvasnicková E
    Physiol Res; 2004; 53(6):683-91. PubMed ID: 15588138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.
    Popelová O; Sterba M; Hasková P; Simůnek T; Hroch M; Guncová I; Nachtigal P; Adamcová M; Gersl V; Mazurová Y
    Br J Cancer; 2009 Sep; 101(5):792-802. PubMed ID: 19623174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.
    Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V
    Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
    Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
    Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
    Lenčová-Popelová O; Jansová H; Jirkovský E; Bureš J; Jirkovská-Vávrová A; Mazurová Y; Reimerová P; Vostatková L; Adamcová M; Hroch M; Pokorná Z; Kovaříková P; Šimůnek T; Štěrba M
    Toxicology; 2016 Nov; 372():52-63. PubMed ID: 27816693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
    Jansová H; Macháček M; Wang Q; Hašková P; Jirkovská A; Potůčková E; Kielar F; Franz KJ; Simůnek T
    Free Radic Biol Med; 2014 Sep; 74():210-21. PubMed ID: 24992833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).
    Bureš J; Jansová H; Stariat J; Filipský T; Mladěnka P; Šimůnek T; Kučera R; Klimeš J; Wang Q; Franz KJ; Kovaříková P
    J Pharm Biomed Anal; 2015 Feb; 105():55-63. PubMed ID: 25527982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
    Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
    Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.
    Lenčová-Popelová O; Jirkovský E; Jansová H; Jirkovská-Vávrová A; Vostatková-Tichotová L; Mazurová Y; Adamcová M; Chládek J; Hroch M; Pokorná Z; Geršl V; Šimůnek T; Štěrba M
    J Mol Cell Cardiol; 2016 Feb; 91():92-103. PubMed ID: 26724189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.
    Lukinova N; Iacovelli J; Dentchev T; Wolkow N; Hunter A; Amado D; Ying GS; Sparrow JR; Dunaief JL
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1440-7. PubMed ID: 19182262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
    Kollárová-Brázdová P; Lenčová-Popelová O; Karabanovich G; Kocúrová-Lengvarská J; Kubeš J; Váňová N; Mazurová Y; Adamcová M; Jirkovská A; Holečková M; Šimůnek T; Štěrbová-Kovaříková P; Roh J; Štěrba M
    Clin Sci (Lond); 2021 Aug; 135(15):1897-1914. PubMed ID: 34318878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
    Voest EE; van Acker SA; van der Vijgh WJ; van Asbeck BS; Bast A
    J Mol Cell Cardiol; 1994 Sep; 26(9):1179-85. PubMed ID: 7815460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy.
    Simůnek T; Klimtová I; Adamcová M; Gersl V; Hrdina R; Sterba M; Kaplanová J; Mazurová Y
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):431-4. PubMed ID: 14618274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
    Li W; Xu B; Xu J; Wu XL
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac troponins following repeated administration of an iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH)--in rabbits.
    Adamcová M; Sterba M; Klimtová I; Simůnek T; Hrdina R; Gersl V; Ponka P
    Acta Medica (Hradec Kralove); 2003; 46(4):171-4. PubMed ID: 14965168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
    Kovaríková P; Mrkvicková Z; Klimes J
    J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications.
    Hrušková K; Potůčková E; Hergeselová T; Liptáková L; Hašková P; Mingas P; Kovaříková P; Šimůnek T; Vávrová K
    Eur J Med Chem; 2016 Sep; 120():97-110. PubMed ID: 27187862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P; Mackova E; Haskova P; Vavrova A; Jirkovsky E; Sterba M; Popelova O; Kalinowski DS; Kovarikova P; Vavrova K; Richardson DR; Simunek T
    Chem Res Toxicol; 2010 Jun; 23(6):1105-14. PubMed ID: 20521781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.